JP Morgan Chase
AZN icon

JP Morgan Chase’s AstraZeneca AZN Stock Holding History

JP Morgan Chase’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$191K Sell
1,000
-61,000
-98% -$11.5M ﹤0.01% 5647
2026
Q1 		$12M Buy
+62,000
New +$12M ﹤0.01% 2508
2025
Q2 		– Sell
-33,100
Closed -$4.87M – 7069
2025
Q1 		$4.87M Sell
33,100
-46,650
-58% -$6.75M ﹤0.01% 3186
2024
Q4 		$10.5M Buy
79,750
+49,750
+166% +$6.96M ﹤0.01% 2650
2024
Q3 		$4.67M Sell
30,000
-22,550
-43% -$3.64M ﹤0.01% 3266
2024
Q2 		$8.2M Buy
52,550
+22,550
+75% +$3.39M ﹤0.01% 2630
2024
Q1 		$4.07M Hold
30,000
– – ﹤0.01% 3274
2023
Q4 		$4.04M Sell
30,000
-28,500
-49% -$3.7M ﹤0.01% 3276
2023
Q3 		$7.92M Sell
58,500
-28,550
-33% -$3.9M ﹤0.01% 2461
2023
Q2 		$12.5M Buy
+87,050
New +$12.8M ﹤0.01% 2097
2022
Q1 		– Sell
-67,946
Closed -$7.92M – 6582
2021
Q4 		$7.92M Hold
67,946
– – ﹤0.01% 2657
2021
Q3 		$8.16M Buy
+67,946
New +$7.91M ﹤0.01% 2579
2021
Q1 		– Sell
-58,750
Closed -$5.87M – 6058
2020
Q4 		$5.87M Buy
58,750
+40,000
+213% +$4.24M ﹤0.01% 2667
2020
Q3 		$2.07M Hold
18,750
– – ﹤0.01% 3210
2020
Q2 		$1.98M Hold
18,750
– – ﹤0.01% 3106
2020
Q1 		$1.68M Hold
18,750
– – ﹤0.01% 3084
2019
Q4 		$1.87M Buy
+18,750
New +$1.77M ﹤0.01% 3430
2019
Q3 		– Sell
-23,700
Closed -$1.94M – 5713
2019
Q2 		$1.94M Buy
+23,700
New +$1.86M ﹤0.01% 3400
2015
Q1 		– Sell
-1,074,800
Closed -$75.6M – 4059
2014
Q4 		$75.6M Buy
+1,074,800
New +$77M 0.02% 739

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
Vanguard Asset Management
Vanguard Asset Management London, Ec4n 8af $148B AUM

JP Morgan Chase's AZN Position: Q2 2026 in Review

JP Morgan Chase increased its AstraZeneca (AZN) stake by 3.3% in Q2 2026, buying an estimated $115M and bringing the position to 19,204,823 shares worth $3.67B. The position accounts for 0.2% of the portfolio, ranked #104.

JP Morgan Chase first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • JP Morgan Chase held 19,204,823 shares of AstraZeneca worth $3.67B as of Q2 2026.
  • JP Morgan Chase bought 613,901 AstraZeneca shares in Q2 2026, an estimated $115M.
  • AstraZeneca made up 0.2% of JP Morgan Chase's portfolio in Q2 2026, its #104 holding.
  • JP Morgan Chase first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
  • 1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.